Business Context and Reporting Period
This Form 8-K filing by Daxor Corporation covers the reporting period ending May 16, 2017. The report discloses a material change in executive management regarding the Chief Financial Officer position.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes rather than financial performance data.
Material Changes
- Executive Departure: Eric Coleman, Chief Financial Officer, was released from his employment on May 10, 2017.
- Executive Appointment: John Wilkens assumed the role of Chief Financial Officer on May 15, 2017.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, contingencies, or unusual items beyond the disclosed personnel changes.
Investor Verification Checklist
- Verify the effective date of John Wilkens' appointment as CFO.
- Confirm the circumstances surrounding Eric Coleman's departure.
- Review subsequent filings for any interim financial reports or further executive changes.